scholarly journals Intestinal Goblet Cells Play a Protective Role Against GVHD Via a Lypd8-Dependent Manner after Allogeneic Hematopoietic Stem Cell Transplantation

Blood ◽  
2018 ◽  
Vol 132 (Supplement 1) ◽  
pp. 64-64
Author(s):  
Takahide Ara ◽  
Daigo Hashimoto ◽  
Eiko Hayase ◽  
Noizat Clara ◽  
Ryu Okumura ◽  
...  

Abstract [Introduction] Emerging evidences suggest that perturbations in the gut microbiota are associated with graft-versus-host disease (GVHD), and dominance of Enterobacteriaceae is related to poor prognosis after allogeneic hematopoietic stem cell transplantation (SCT) (Taur Y, Blood. 2014; 124:1174-1182). We recently reported that degree of goblet-cell loss was significantly corelated with poor prognosis in 90 patients who underwent SCT in our institute (Ara, et al. 2018 Tandem BMT meeting #220). Goblet cells play a critical role in forming the mucus layer that constitutes not only physical but also chemical barrier, by retaining antimicrobial peptides, against invading microbes from gut lumen. In the current study, we explored the mechanism by which goblet cells protect recipients against GVHD, especially focusing on the role of antimicrobial peptide Lypd8 that is produced by colon epithelial cells and specifically suppresses motilities and biotranslocation of flagellated bacteria including harmful Enterobacteriaceae. [Methods] Mice were lethally irradiated and injected with 5 × 106 bone marrow cells and 7.5 × 106 splenocytes from allogeneic or syngeneic donors on day 0. Recipient mice were intraperitoneally injected with 0.3 mg recombinant mouse IL-25 (rmIL-25) or vehicle from day -6 to 0. [Results] In the B6 → B6D2F1 model, goblet cells in the colon were significantly decreased in association with severe GVHD (Figure A). Fluorescent in situ hybridization (FISH) using the universal bacterial probe EUB338 showed bacterial translocation to the colonic mucosa after SCT. Quantitative PCR targeting bacterial 16S rRNA confirmed that bacterial load in the lamina propria was significantly increased in allogeneic mice compared to syngeneic controls and naive mice (Figure B). Immunofluorescent staining showed Lypd8 at the border of the inner mucus layer and colonic epithelial cells was reduced in allogeneic mice. To evaluate role of Lypd8 in GVHD, lethally irradiated B6-Lypd8-/- mice and wild type (WT) B6 controls were transplanted from BALB/c mice. Both FISH and quantitative PCR showed an increased bacterial translocation into the colonic mucosa in Lypd8-deficient recipients compared to WT recipients (Figure C), indicating that Lypd8 plays a protective role against bacterial translocation into the colonic mucosa. In association with enhanced bacterial translocation, significantly more donor T cells were infiltrated into the gut and liver in Lypd8-/- recipients compared to WT controls (Figure D). Strikingly, GVHD was significantly more severe with shorter survival in B6-Lypd8-/- mice compared to WT recipients (Figure E). GVHD exacerbation in Lypd8-/- mice was reproduced when Lypd8-/- recipients were co-housed with WT recipients for 4 weeks before SCT, excluding the virulent microbiota in Lypd8-/- mice as the potential mechanism of GVHD exacerbation in these mice. Finally, we tested if the goblet-cell protection could attenuate GVHD. Pre-transplant administration of IL-25 mitigated goblet-cell loss and bacterial translocation, reduced plasma levels of IFN-g and IL-6, and ameliorated GVHD mortality. Protective effects of pre-transplant IL-25 was abrogated when Lypd8-/- mice were used as recipients, suggesting that goblet cells protect recipients against GVHD via a Lypd8-dependent manner. [Conclusion] Our results demonstrated that goblet cells suppress bacterial translocation into the colon mucosa and play a protective role against GVHD via a Lypd8-dependent manner. Since increase in flagellated bacteria in the gut could be associated with GVHD exacerbation, goblet cells and Lypd8 could be potentially prophylactic and therapeutic targets for GVHD. Figures: (A) The amount of goblet cells in the colon of allogeneic or syngeneic recipients, or naïve mice are shown. (B) Colon samples were harvested from syngeneic and allogeneic recipients on day +7 after SCT. DNA was extracted from colon samples after removing epithelial cells by incubating with EDTA and subjected to quantitative PCR with 16S rRNA specific primers. (C-E) WT or Lypd8-/- B6 mice were lethally irradiated and transplanted from allogeneic BALB/c mice. Bacterial load in the colon lamina propria (C) and absolute numbers of donor T cells in the liver and colon (D) on day +5, and survival curves (E) after SCT are shown. *; p<0.05, **; p<0.01, ***; p<0.005. Disclosures No relevant conflicts of interest to declare.

2020 ◽  
Vol 12 (550) ◽  
pp. eaaw0720
Author(s):  
Takahide Ara ◽  
Daigo Hashimoto ◽  
Eiko Hayase ◽  
Clara Noizat ◽  
Ryo Kikuchi ◽  
...  

Graft-versus-host disease (GVHD) and infection are major obstacles to successful allogeneic hematopoietic stem cell transplantation (HSCT). Intestinal goblet cells form the mucus layers, which spatially segregate gut microbiota from host tissues. Although it is well known that goblet cell loss is one of the histologic features of GVHD, effects of their loss in pathophysiology of GVHD remain to be elucidated. In mouse models of allogeneic HSCT, goblet cells in the colon were significantly reduced, resulting in disruption of the inner mucus layer of the colon and increased bacterial translocation into colonic mucosa. Pretransplant administration of interleukin-25 (IL-25), a growth factor for goblet cells, protected goblet cells against GVHD, prevented bacterial translocation, reduced plasma concentrations of interferon-γ (IFN-γ) and IL-6, and ameliorated GVHD. The protective role of IL-25 was dependent on Lypd8, an antimicrobial molecule produced by enterocytes in the colon that suppresses motility of flagellated bacteria. In clinical colon biopsies, low numbers of goblet cells were significantly associated with severe intestinal GVHD, increased transplant-related mortality, and poor survival after HSCT. Goblet cell loss is associated with poor transplant outcome, and administration of IL-25 represents an adjunct therapeutic strategy for GVHD by protecting goblet cells.


2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S188-S188
Author(s):  
J H Kim ◽  
J B Ahn ◽  
D H Kim ◽  
S Kim ◽  
H W Ma ◽  
...  

Abstract Background The enzyme glutathione S-transferase theta 1 (GSTT1) is involved in detoxifying chemicals, including reactive oxygen species (ROS). Oxidative stress plays a key role in the pathogenesis of inflammatory bowel disease (IBD). Although mutation of the GSTT1 gene increases IBD susceptibility, the underlying mechanisms remain unexplained. Methods The Gstt1 gene was intrarectally or intraperitoneally delivered to mice with dextran sodium sulphate (DSS)-induced colitis. The GSTT1 gene was knocked down or knocked out using short interfering RNA or genome editing, respectively. Protein and mRNA expression and differentiation of goblet cells were evaluated. Results We identified decreased expression of GSTT1 in inflamed tissues from IBD patients and mice compared with their control counterparts, respectively. We also noted attenuation of colitis through gene transfer of Gstt1 to DSS-treated mice via the interleukin-22 (IL-22) pathway. GSTT1 was differently regulated by pathogens and host immune responses. Down-regulation of GSTT1 reduced innate defence responses and goblet cell differentiation. The GSTT1 mutation in intestinal epithelial cells as well as IBD patients diminished its dimerisation, which was connected to insufficient phosphorylation of signal transducer and activator of transcription 3 and p38/mitogen-activated protein kinase by their common activator, IL-22. Conclusion GSTT1 ameliorated IL-22 in colitis in a dependent manner and contributed as a modulator of goblet cells through sensing pathogens and host immune responses. Its mutations are linked to chronic intestinal inflammation due to its insufficient dimerisation. Our results provide new insights into GSTT1 mutations and their functional consequences in IBDs.


2017 ◽  
Vol 114 (29) ◽  
pp. E5881-E5890 ◽  
Author(s):  
Soung-Min Lee ◽  
Ha Young Park ◽  
Young-Sill Suh ◽  
Eun Hye Yoon ◽  
Juyang Kim ◽  
...  

The lung is a prototypic organ that was evolved to reduce immunopathology during the immune response to potentially hazardous endogenous and exogenous antigens. In this study, we show that donor CD4+ T cells transiently induced expression of indoleamine 2,3-dioxygenase (IDO) in lung parenchyma in an IFN-γ–dependent manner early after allogeneic hematopoietic stem cell transplantation (HSCT). Abrogation of host IDO expression by deletion of the IDO gene or the IFN-γ gene in donor T cells or by FK506 treatment resulted in acute lethal pulmonary inflammation known as idiopathic pneumonia syndrome (IPS). Interestingly, IL-6 strongly induced IDO expression in an IFN-γ–independent manner when deacetylation of STAT3 was inhibited. Accordingly, a histone deacetylase inhibitor (HDACi) could reduce IPS in the state where IFN-γ expression was suppressed by FK506. Finally, l-kynurenine produced by lung epithelial cells and alveolar macrophages during IPS progression suppresses the inflammatory activities of lung epithelial cells and CD4+ T cells through the aryl hydrocarbon receptor pathway. Taken together, our results reveal that IDO is a critical regulator of acute pulmonary inflammation and that regulation of IDO expression by HDACi may be a therapeutic approach for IPS after HSCT.


2021 ◽  
pp. 69-75
Author(s):  
Anne Hedengran ◽  
Xenia Begun ◽  
Olivia Müllertz ◽  
Zaynab Mouhammad ◽  
Rupali Vohra ◽  
...  

<b><i>Introduction:</i></b> Most intraocular pressure (IOP)-lowering eye drops are preserved with benzalkonium chloride (BAK). This can increase side effects and decrease adherence. Particularly, damage to the mucin-producing conjunctival goblet cells may be an issue due to instability of the tear film. We aimed to investigate the effect of IOP-lowering eye drops preserved with BAK on cultured human conjunctival goblet cells. <b><i>Methods:</i></b> Eye drops Brimonidine Tartrate Teva (BT) with 0.005% BAK, Dorzolamide Stada (DS) with 0.0075% BAK, Optimol<sup>®</sup> (OP) with 0.01% BAK, and Latanoprost Teva (LT) with 0.02% BAK were included. Human primary cultured goblet cell survival was evaluated using a lactate dehydrogenase assay on human goblet cells after treatment for 30 min and 6 h with the different anti-glaucoma drug formulations. <b><i>Results:</i></b> All eye drops examined, except BT, reduced goblet cell survival. The impact of eye drops on goblet cell viability was correlated with the time of exposure as well as to the concentration of BAK. After 30 min of exposure, cell viability was 93% for BT (0.005% BAK; <i>p</i> = 0.93), 71% for DS (0.0075% BAK; <i>p</i> = 0.067), 70% for OP (0.01% BAK; <i>p</i> = 0.054), and 69% for LT (0.02% BAK; <i>p</i> = 0.022), and exposure for 6 h reduced cell survival to 74% for BT (<i>p</i> = 0.217), 52% for DS (<i>p</i> = 0.011), 34% for OP (<i>p</i> = 0.017), and 31% for LT (<i>p</i> = 0.0007). <b><i>Conclusion:</i></b> LT, OP, and DS reduced human goblet cell survival in a time-dependent manner. BT did not affect goblet cell survival. Cell survival was correlated with the BAK concentration in the eye drops making 0.02% BAK-preserved LT most toxic and 0.005% BAK-preserved BT least toxic. Based on the present study, decreasing BAK in eye drops for chronic use seems important to reduce damage to the goblet cells. However, future studies are needed to further explore this finding.


1985 ◽  
Vol 33 (4) ◽  
pp. 360-366 ◽  
Author(s):  
L Luciano ◽  
E Reale

After fixation in the presence of filipin, the membrane of the goblet cell granules of the distal colonic mucosa (guinea pig) displays, in freeze-fracture replicas, a rhombic pattern composed of intersecting "lines" of unknown nature. The filipin-cholesterol complexes of the granule membrane are ordered according to the same geometry. This arrangement--but not the "lines"--has been found for the filipin-cholesterol complexes of other membranes of the same goblet cells as well as of other colonic cells. These observations indicate that in some biological membranes cholesterol has an ordered distribution, comparable to that suggested by investigations on artificial membranes.


1952 ◽  
Vol 5 (1) ◽  
pp. 169 ◽  
Author(s):  
DF Waterhouse

Goblet cells and columnar cells occur, together with regenerative cells, in the midgut epithelium of lepidopterous larvae. The columnar cells have an appearance typical of the simple epithelial cells that occur in the midgut of many insects. The goblet cells are highly differentiated and, although there are marked variations between species, such as in frequency of occurrence, in shape, in staining reactions, and so on, their basic structure is very similar. Bodian's 'ProtargoI' staining technique provides excellent differentiation of goblet cells. Each goblet cell has a basally situated nucleus and contains an internal cavity, which is bordered by a faintly striated lining. No opening permitting direct movement of material from the cavity into the lumen has been observed. Available evidence suggests that materials moving out of the cavity pass through a bounding membrane. Unlike columnar cells, goblet cells do not possess a striated border on their lumen surface.


Antibiotics ◽  
2021 ◽  
Vol 10 (8) ◽  
pp. 900
Author(s):  
Arthika Manoharan ◽  
Samantha Ognenovska ◽  
Denis Paino ◽  
Greg Whiteley ◽  
Trevor Glasbey ◽  
...  

Urinary tract infections (UTIs) affect more than 150 million individuals annually. A strong correlation exists between bladder epithelia invasion by uropathogenic bacteria and patients with recurrent UTIs. Intracellular bacteria often recolonise epithelial cells post-antibiotic treatment. We investigated whether N-acetylcysteine (NAC) could prevent uropathogenic E. coli and E. faecalis bladder cell invasion, in addition to its effect on uropathogens when used alone or in combination with ciprofloxacin. Methods: An invasion assay was performed in which bacteria were added to bladder epithelial cells (BECs) in presence of NAC and invasion was allowed to occur. Cells were washed with gentamicin, lysed, and plated for enumeration of the intracellular bacterial load. Cytotoxicity was evaluated by exposing BECs to various concentrations of NAC and quantifying the metabolic activity using resazurin at different exposure times. The effect of NAC on the preformed biofilms was also investigated by treating 48 h biofilms for 24 h and enumerating colony counts. Bacteria were stained with propidium iodide (PI) to measure membrane damage. Results: NAC completely inhibited BEC invasion by multiple E. coli and E. faecalis clinical strains in a dose-dependent manner (p < 0.01). This was also evident when bacterial invasion was visualised using GFP-tagged E. coli. NAC displayed no cytotoxicity against BECs despite its intrinsic acidity (pH ~2.6), with >90% cellular viability 48 h post-exposure. NAC also prevented biofilm formation by E. coli and E. faecalis and significantly reduced bacterial loads in 48 h biofilms when combined with ciprofloxacin. NAC visibly damaged E. coli and E. faecalis bacterial membranes, with a threefold increase in propidium iodide-stained cells following treatment (p < 0.05). Conclusions: NAC is a non-toxic, antibiofilm agent in vitro and can prevent cell invasion and IBC formation by uropathogens, thus providing a potentially novel and efficacious treatment for UTIs. When combined with an antibiotic, it may disrupt bacterial biofilms and eliminate residual bacteria.


2020 ◽  
Author(s):  
Manish Bodas ◽  
Andrew R. Moore ◽  
Bharathiraja Subramaniyan ◽  
Constantin Georgescu ◽  
Jonathan D. Wren ◽  
...  

AbstractChronic obstructive pulmonary disease (COPD) is the 3rd leading cause of death in the United States and is primarily caused by cigarette smoking. Increased numbers of mucus-producing secretory (“goblet”) cells defined as goblet cell metaplasia or hyperplasia (GCMH), contributes significantly to COPD pathophysiology. The objective of this study was to determine whether NOTCH signaling regulates goblet cell differentiation in response to cigarette smoke. Primary human bronchial epithelial cells (HBECs) from nonsmokers and COPD smokers were differentiated in vitro on air-liquid interface and exposed to cigarette smoke extract (CSE) for 7 days. NOTCH signaling activity was modulated using (1) the NOTCH/γ-secretase inhibitor Dibenzazepine (DBZ), (2) lentiviral over-expression of the NOTCH3-intracellular domain (NICD3) or (3) NOTCH3-specific siRNA. Cell differentiation and response to CSE were evaluated by qPCR, Western blotting, immunostaining and RNA-Seq. We found that CSE exposure of nonsmoker airway epithelium induced goblet cell differentiation characteristic of GCMH. Treatment with DBZ suppressed CSE-dependent induction of goblet cell differentiation. Furthermore, CSE induced NOTCH3 activation, as revealed by increased NOTCH3 nuclear localization and elevated NICD3 protein levels. Over-expression of NICD3 increased the expression of goblet cell associated genes SPDEF and MUC5AC, whereas NOTCH3 knockdown suppressed CSE-mediated induction of SPDEF and MUC5AC. Finally, CSE exposure of COPD airway epithelium induced goblet cell differentiation in a NOTCH3-dependent manner. These results identify NOTCH3 activation as one of the important mechanisms by which cigarette smoke induces goblet cell differentiation, thus providing a novel potential strategy to control GCMH-related pathologies in smokers and patients with COPD.


2021 ◽  
Author(s):  
Hassan Melhem ◽  
Berna Kaya ◽  
Tanay Kaymak ◽  
Philipp Wuggenig ◽  
Emilio Flint ◽  
...  

Goblet cells are essential for maintaining intestinal health and for the defense against invasive bacterial infection. However, the molecular pathways that regulate goblet cell function remain largely unknown. Although GPR35 is highly expressed in colonic epithelial cells, its importance in promoting the epithelial barrier is unclear. Here we found that epithelial Gpr35 plays a critical role in goblet cell function. Genetic deletion of Gpr35 in epithelial cells but not in from macrophages results in goblet cell depletion and dysbiosis, rendering these mice more susceptible to Citrobacter rodentium infection. Mechanistically, scRNA-seq analysis indicates that signaling of epithelial Gpr35 is essential to maintain normal pyroptosis levels in goblet cells. Our work shows how the epithelial presence of Gpr35 is a critical element for the function of goblet cell-mediated symbiosis between host and microbiota.


2019 ◽  
Vol 44 (2) ◽  
pp. 82
Author(s):  
Maretha Amrayni ◽  
Elsa Gustianty ◽  
Susi Heryati ◽  
Andika Prahasta ◽  
Maula Rifada ◽  
...  

Introduction : The longterm use of topical antiglaucoma might cause ocular surface instability due to active substance or preservative used. Impression cytology examination may reveal superficial epithelial cells on conjunctiva and cornea, including goblet cells. Goblet cell density decrease is the most important parameter on evaluation of ocular surface disorder. Objective : This study was to understand ocular surface remodeling due to active substance of topical antiglaucoma with impression cytology examination among the patient prior and 3 months after therapy. Methods : This was a randomized controlled trial study with single blind masking. A total of 45 eyes from 31 patients were used as subject and distributed onto three groups treatment, which were timolol maleat 0.5%, latanoprost 0.005%, and latanoprost-timolol maleat fixed combination. All topical antiglaucoma in this study were preservative free. Result : There were differences between 3 groups in goblet cells density after 3 months therapy (p=0,030). Goblet cell density in timolol group was lower than latanoprost (p=0,041) and fixed combination (p=0,045). There was no significantly difference between 3 groups in conjunctival epithelial metaplasia degree (p=0,706) and cell to cell contact degree in corneal epithelial cells (p=0.66) after 3 months therapy. Conjunctival epithelial metaplasia degree were increased among group of timolol (p=0,008) and fixed combination (p=0,046). Conclusion : Timolol maleat 0,5% caused lower goblet cell density after 3 months therapy compare with latanoprost and fixed combination. There was no significantly difference in conjunctival epithelial metaplasia and cell to cell contact degree in corneal epithelial cells among these glaucoma treatment groups.


Sign in / Sign up

Export Citation Format

Share Document